Topical cis-urocanic acid prevents ocular surface irritation in both IgE -independent and -mediated rat model

Jauhonen H.-M., Laihia J., Oksala O., Viiri J., Sironen R., Alajuuma P., Kaarniranta K., Leino L.

Affiliations

Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland; Institute of Clinical Medicine, Department of Ophthalmology, University of Eastern Finland, Kuopio, Finland; Department of Ophthalmology, University of Eastern Finland and Kuopio University Hospital, Finland, P.O. Box 1627, Kuopio, FIN-70211, Finland; BioCis Pharma Ltd, Turku, Finland; Santen Oy, Tampere, Finland; Institute of Clinical Medicine, Department of Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland; Department of Pathology, Kuopio University Hospital, Kuopio, Finland

Related Publications

Blautain, B.; Rabut, G.; Dupas, B.; Riancho, L.; Liang, H.; Luzu, J.: Labbé, A.; Garrigue J.-S.; Brignole-Baudouin, F.; Baudouin, C.; Kessal, K.

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.